Early cellular hallmarks of epithelial cancers include the disruption of cell polarity, cell morphology and tissue architecture. Our lab has recently identified ZYG11A as a novel regulator of mammalian epithelial cell morphology1. Although a role for these genes has been described in cell cycle control and HPV16 E7 viral oncoprotein function, little is known about the function ZYG11A and other ZYG11 family members in the regulation of cell polarity and cell morphology2,3.
To investigate the function of ZYG11 family members in epithelial development and cellular organization, I have used a combination of gene expression, live cell imaging, and functional analysis in mammalian epithelial cells as well as generated ZYG11 homologue mutants in Drosophila and zebrafish. Our initial studies provide evidence for divergent functions for individual ZYG11 family members in mammalian cells as well as a fundamental requirement for ZYG11 in Drosophila and zebrafish development.
As ZYG11A has been implicated in protein ubiquitination, I hypothesise that the loss of ZYG11A will deregulate the turnover of a large network of proteins4. Using RNAi screening of candidate biochemical and genetic interactors, I have initially identified key adhesion and polarity proteins as potential targets of ZYG11A regulation. Through the implementation of proximity-dependent biotin labelling, I aim to build a better understanding of the ubiquitination targets and pathways regulated by the ZYG11 family that contribute to the regulation of cell polarity, morphology, and how this may ultimately regulate the initiation and progression of epithelial cancer.